US Stock MarketDetailed Quotes
NKTR Nektar Therapeutics
- 1.3600
- +0.1200+9.68%
Close Apr 22 16:00 ET
249.72MMarket Cap-937P/E (TTM)
1.4100High1.2900Low1.97MVolume1.3100Open1.2400Pre Close2.70MTurnover1.21%Turnover RatioLossP/E (Static)183.62MShares1.750052wk High1.91P/B221.83MFloat Cap0.412652wk Low--Dividend TTM163.11MShs Float111.3600Historical High--Div YieldTTM9.68%Amplitude0.4126Historical Low1.3680Avg Price1Lot Size
Nektar Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 36.64%-192.61M | 18.47%-47.05M | 49.18%-42.12M | 31.30%-51.52M | 41.29%-51.92M | 26.33%-304.01M | 61.92%-57.7M | 18.04%-82.89M | 9.54%-74.99M | -14.71%-88.42M |
| Net income from continuing operations | 25.03%-276.06M | 29.50%-42.08M | 22.37%-45.84M | 67.86%-51.12M | -51.58%-137.02M | 29.71%-368.2M | 59.02%-59.69M | 54.47%-59.05M | -26.73%-159.07M | 26.49%-90.39M |
| Operating gains losses | 117.41%6.4M | ---- | ---- | ---- | ---- | -558.10%-36.75M | -968.41%-3.33M | --0 | --0 | -2,190.49%-33.43M |
| Depreciation and amortization | -40.02%7.82M | -48.08%1.65M | -36.68%1.7M | -37.05%2.17M | -38.28%2.3M | -7.89%13.03M | -7.39%3.18M | -26.05%2.68M | -2.99%3.44M | 5.28%3.73M |
| Deferred tax | -105.17%-140K | -36.71%1.71M | ---15K | ---27K | ---1.81M | 2,754.90%2.71M | --2.71M | --0 | --0 | --0 |
| Other non cash items | -21.30%-43.59M | -7.37%-11.19M | 66.03%-4.11M | -52.94%-14.7M | -257.03%-13.59M | -436.44%-35.93M | -180.28%-10.43M | -1,885.67%-12.09M | -363.23%-9.61M | -318.59%-3.81M |
| Change In working capital | -4,124.39%-19.8M | 41.35%-4.73M | 83.85%-4.49M | -141.52%-9.06M | -110.49%-1.52M | 102.14%492K | 84.40%-8.07M | -648.17%-27.77M | 48.26%21.82M | -18.26%14.51M |
| -Change in receivables | -71.07%4.78M | -82.00%999K | 43.05%-869K | -91.79%1.66M | 138.64%2.99M | 33.19%16.51M | 121.86%5.55M | -1,140.65%-1.53M | 6,992.63%20.21M | -179.40%-7.73M |
| -Change in inventory | 120.55%699K | 838.62%1.07M | 153.40%1.12M | 71.45%-454K | -344.79%-1.03M | -568.17%-3.4M | 69.21%-145K | -192.44%-2.09M | -172.54%-1.59M | 127.84%422K |
| -Change in payables and accrued expense | -18.78%-20.01M | 77.82%-3.16M | 105.85%1.08M | -742.25%-10.65M | -142.41%-7.28M | 51.34%-16.84M | 54.61%-14.26M | -714.67%-18.48M | -230.44%-1.26M | 339.37%17.17M |
| -Change in other current assets | -48.12%3.58M | -142.40%-867K | -24.80%-3.45M | -51.48%2.31M | 95.22%5.59M | 367.05%6.91M | 160.15%2.05M | 74.32%-2.77M | -11.83%4.76M | -53.68%2.86M |
| -Change in other working capital | -230.22%-8.85M | -120.53%-2.77M | 18.84%-2.36M | -541.53%-1.93M | -199.94%-1.79M | -214.53%-2.68M | 93.36%-1.26M | -159.50%-2.91M | -105.13%-301K | -83.02%1.79M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 36.64%-192.61M | 18.47%-47.05M | 49.18%-42.12M | 31.30%-51.52M | 41.29%-51.92M | 26.33%-304.01M | 61.92%-57.7M | 18.04%-82.89M | 9.54%-74.99M | -14.71%-88.42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -61.85%139.56M | -56.56%17.38M | -49.36%56.41M | -70.09%25.17M | -68.84%40.6M | 80.41%365.84M | -66.71%40.01M | 13,521.08%111.4M | 15.35%84.15M | 1,145.73%130.28M |
| Net PPE purchase and sale | -94.95%380K | -101.87%-237K | 769.61%1.21M | 79.23%-162K | 89.70%-433K | 150.17%7.52M | 315.13%12.68M | 93.84%-181K | 76.23%-780K | -46.14%-4.2M |
| Net investment purchase and sale | -61.16%139.18M | -35.53%17.62M | -50.53%55.2M | -70.17%25.33M | -69.49%41.03M | 64.54%358.32M | -78.33%27.33M | 5,198.01%111.58M | 11.41%84.93M | 908.56%134.48M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -61.85%139.56M | -56.56%17.38M | -49.36%56.41M | -70.09%25.17M | -68.84%40.6M | 80.41%365.84M | -66.71%40.01M | 13,521.08%111.4M | 15.35%84.15M | 1,145.73%130.28M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -98.01%30K | -88.35%12K | 0 | -96.15%18K | 0 | -95.84%1.51M | -95.96%103K | 0 | -96.16%467K | -94.75%938K |
| Proceeds from stock option exercised by employees | -96.04%30K | -88.35%12K | --0 | -96.15%18K | --0 | -97.72%758K | -94.28%103K | --0 | -95.91%467K | -98.90%188K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | -75.00%750K | --0 | --0 | --0 | 0.00%750K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -98.01%30K | -88.35%12K | --0 | -96.15%18K | --0 | -95.84%1.51M | -95.96%103K | --0 | -96.16%467K | -94.75%938K |
| Net cash flow | ||||||||||
| Beginning cash position | 249.86%88.23M | -38.61%64.92M | -34.58%50.73M | 13.18%76.96M | 249.86%88.23M | -87.32%25.22M | 95.79%105.76M | -49.10%77.55M | -54.72%67.99M | -87.32%25.22M |
| Current changes in cash | -183.70%-53.01M | -68.61%-29.65M | -49.87%14.29M | -373.69%-26.33M | -126.45%-11.32M | 136.47%63.34M | 38.91%-17.59M | 129.00%28.51M | 333.81%9.62M | 187.74%42.79M |
| Effect of exchange rate changes | 118.96%62K | -85.45%8K | 66.78%-98K | 252.86%107K | 364.71%45K | -255.43%-327K | 650.00%55K | -1,080.00%-295K | -89.19%-70K | 15.00%-17K |
| End cash Position | -60.02%35.28M | -60.02%35.28M | -38.61%64.92M | -34.58%50.73M | 13.18%76.96M | 249.86%88.23M | 249.86%88.23M | 95.79%105.76M | -49.10%77.55M | -54.72%67.99M |
| Free cash flow | 37.53%-193.47M | 18.78%-47.28M | 49.25%-42.15M | 31.79%-51.69M | 43.49%-52.35M | 27.58%-309.68M | 63.02%-58.22M | 20.18%-83.07M | 12.08%-75.77M | -15.84%-92.63M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg